Benign Prostatic Hyperplasia (BPH) Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Benign Prostatic Hyperplasia (BPH) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)
The Cleveland Clinic20 enrolled1 locationNCT07016620
Recruiting
Not Applicable

Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging

Benign Prostatic Hyperplasia (BPH)
Chinese PLA General Hospital30 enrolled1 locationNCT06817733
Recruiting
Not Applicable

Post-Market Study to Assess iTind Safety in Comparison to UroLift

Benign Prostatic Hyperplasia (BPH)
Olympus Corporation of the Americas206 enrolled18 locationsNCT04757116
Recruiting
Not Applicable

Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia

Lower Urinary Track SymptomsBenign Prostatic Hyperplasia (BPH)
Centre hospitalier de l'Université de Montréal (CHUM)100 enrolled1 locationNCT06769997
Recruiting
Not Applicable

Bipolar Resection vs Enucleation of Prostate

Benign Prostatic Hyperplasia With Outflow ObstructionBenign Prostatic Hyperplasia (BPH) Requiring Surgical ResectionBenign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms+1 more
South Valley University100 enrolled1 locationNCT06983444
Recruiting
Not Applicable

The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults

Benign Prostatic Hyperplasia (BPH)
TCI Co., Ltd.50 enrolled1 locationNCT04266418
Recruiting
Phase 2

Effects of TNF Blockade on Human BPH/LUTS

Benign Prostatic Hyperplasia (BPH)
Endeavor Health70 enrolled1 locationNCT06062875
Recruiting
Not Applicable

Aquablation vs. Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia in Medium to Large Size Prostates

Benign Prostatic Hyperplasia (BPH)
Dr. med. Gautier Müllhaupt120 enrolled1 locationNCT04560907
Recruiting

Safety and Feasibility of a Transurethral Endoscopic Procedure for the Luminal Restoration of the Prostatic Urethra: A Preliminary Investigation

Benign Prostatic Hyperplasia (BPH)
NeoTract, Inc.70 enrolled1 locationACTRN12609000760279